Extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting

An immunomagnetic bead method and surface protein technology, applied in the field of molecular biology, can solve the problem of rarely reported extracellular vesicle aptamer screening, achieve important social value and clinical significance, simple and rapid recovery rate, and reduce screening. effect of time

Inactive Publication Date: 2020-02-14
NANJING DRUM TOWER HOSPITAL
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Based on Cell-SELEX technology, a variety of tumor cell-specific aptamers have been screened, but...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting
  • Extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting
  • Extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment 1

[0052] The screening of specific aptamers for extracellular vesicle surface proteins in human lung adenocarcinoma cell A549 cells based on the immunomagnetic bead method comprises the following steps:

[0053] 1) Synthesize upstream and downstream primers and random libraries

[0054] The specific primer pair F / R and the random library sequence were synthesized by Shanghai Sangon Biotechnology Co., Ltd. The sequence of the upstream primer F is shown in SEQ ID NO: 1, and the sequence of the downstream primer R is shown in SEQ ID NO: 2. The random library The sequence of is shown in SEQ ID NO: 3:

[0055] Upstream primer F (SEQ ID NO: 1): 5'-FAM-GTTGGTGAGGTAACGGCTCA-3'

[0056] Downstream primer R (SEQ ID NO: 2): 5'-biotin-CGGATAACGCTTGCCACCTA-3';

[0057] Random library: 35'-GTTGGTGAGGTAACGGCTCA-40nt-TAGGTGGCAAGCGTTATCCG-3';

[0058] Further, the random library in step 1) is an 80nt single-stranded oligonucleotide, the middle 40nt of the single-stranded oligonucleotide is 40...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting. The extracellular vesicle surface protein specific aptamer screening technology includes the following steps of: 1) synthesizing upstream primers, downstream primers and a random library; 2) culturing target cells and obtaining a cell culture supernatant;3) using a grain diameter selection method for extracting extracellular vesicles; 4) using immunomagnetic beads of which the surfaces are modified with CD63 antibodies for capturing the extracellularvesicles; 5) conducting positive screening to acquire library sequences capable of being combined with target extracellular vesicles; 6) conducting positive screening and negative screening alternatively to acquire specific target nucleic acid aptamers; and 7) adopting a flow cytometry technology to detect the enrichment condition of the library. According to the extracellular vesicle surface protein specific aptamer screening technology based on magnetic-activated cell sorting, the grain diameter selection method is adopted to extract the extracellular vesicles, the extracellular vesicles are extracted easily and rapidly, and the recovery rate of the extracellular vesicles is high; the immunomagnetic beads of which the surfaces are modified with the CD63 antibodies are used for capturingexosomes, and the extracellular vesicles can be separated rapidly; and furthermore, positive screening and negative screening are conducted alternatively, thus, the screening efficiency of the targetnucleic acid aptamers can be improved, and by utilizing the screened aptamers, disease liquid biopsies and treatment which take extracellular vesicle surface proteins as targets can be conducted.

Description

technical field [0001] The invention belongs to the field of molecular biology, and in particular relates to an extracellular vesicle surface protein-specific aptamer screening technology based on an immunomagnetic bead method. Background technique [0002] Extracellular Vesicles (EVs) are vesicle-like bodies with a double-membrane structure that are shed from the cell membrane or secreted by the cell, with a diameter ranging from 40nm to 1000nm. They are released from the cell to the extracellular environment and exist in the blood. , saliva, amniotic fluid, breast milk and urine and other body fluids. EVs contain specific substances in their source cells, including proteins (such as cytokines, membrane receptor proteins, cytoskeletal proteins, heat shock proteins, etc.), nucleic acids (such as DNA, mRNA, small interfering RNA, long non-coding RNA, etc.) and lipids, and when different physiological conditions and diseases occur, proteins and nucleic acids in EVs are differ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/115C12N15/10
CPCC12N15/1065C12N15/115C12N2310/16
Inventor 李智洋何农跃何磊
Owner NANJING DRUM TOWER HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products